Announcements Trials
Browse Landscape

Phase

Phase 2 190Phase 3 46Phase 1 43Phase 1/2 25Phase NA 8Phase 2/3 7Phase 4 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 15Breast 5Tumor-Agnostic 3Gynecologic 3Thoracic 2Other solid neoplasm 1

Conditions

Non-Squamous Non-Small Cell Lung Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 16Pemetrexed 15Cisplatin 15Erlotinib Hydrochloride 13icotinib 8Propofol 7Gefitinib 7Gemcitabine 6Docetaxel 6endostar protein 5Saline Solution 5Paclitaxel 5Nivolumab 5Endostatins 5tislelizumab 4lorlatinib 4anlotinib 4Vinorelbine 4Sevoflurane 4Drug Therapy 4Afatinib 4pembrolizumab 3durvalumab 3atezolizumab 3Zoledronic Acid 3Radiotherapy 3Dexamethasone 3Acetaminophen 3trilaciclib 2pegfilgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Bevacizumab × Thoracic × Clear all
NCT02316327 2016-10-05

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Completed
19 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00451906 2016-05-24

A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Hoffmann-La Roche

Phase 4 Completed
2,252 enrolled 10 charts
Thoracic

Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡